The deoxyuridine suppression test: a review of its clinical and research applications.
D000437:Alcoholism / Q000150:complications; D000743:Anemia, Hemolytic / Q000150:complications; D000927:Anticonvulsants / Q000009:adverse effects; D001854:Bone Marrow Cells; D001855:Bone Marrow Diseases / Q000150:complications; D002477:Cells / Q000378:metabolism; D003857:Deoxyuridine / Q000494:pharmacology; D004913:Erythrocytes, Abnormal; D005260:Female; D005472:Fluorouracil / Q000494:pharmacology; D005492:Folic Acid / Q000494:pharmacology; D005494:Folic Acid Deficiency; D005575:Formyltetrahydrofolates / Q000494:pharmacology; D006710:Homocysteine / Q000494:pharmacology; D006801:Humans; D007037:Hypothyroidism / Q000150:complications; D008213:Lymphocyte Activation; D008715:Methionine / Q000494:pharmacology; D011247:Pregnancy; D011248:Pregnancy Complications; D013223:Statistics as Topic; D013763:Tetrahydrofolates / Q000494:pharmacology; D014805:Vitamin B 12 / Q000494:pharmacology; D014806:Vitamin B 12 Deficiency / Q000139:chemically induced
D000927:Anticonvulsants; D005575:Formyltetrahydrofolates; D013763:Tetrahydrofolates; D006710:Homocysteine; D005492:Folic Acid; D008715:Methionine; D014805:Vitamin B 12; C005984:5-methyltetrahydrofolate; D005472:Fluorouracil; D003857:Deoxyuridine